ESR1 and ovarian cancer: On this premise, Chan et al. (2018) noticed that genistein (in a dose-dependent trend) significantly reduced both migration and invasive ability of ER-positive ovarian cancer cells (SKOV-3 positive for ERα and A2780CP expressing ERβ) by suppressing FAK signaling [93].